187.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt JNJ?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$190.90
Offen:
$192.92
24-Stunden-Volumen:
6.37M
Relative Volume:
0.75
Marktkapitalisierung:
$452.24B
Einnahmen:
$90.62B
Nettoeinkommen (Verlust:
$22.66B
KGV:
20.09
EPS:
9.35
Netto-Cashflow:
$18.18B
1W Leistung:
-0.59%
1M Leistung:
+5.46%
6M Leistung:
+21.65%
1J Leistung:
+16.20%
Johnson Johnson Stock (JNJ) Company Profile
Firmenname
Johnson Johnson
Sektor
Telefon
732-524-2455
Adresse
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Vergleichen Sie JNJ mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
JNJ
Johnson Johnson
|
187.78 | 459.32B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
LLY
Lilly Eli Co
|
811.99 | 747.19B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
ABBV
Abbvie Inc
|
228.61 | 407.19B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
129.86 | 251.72B | 53.40B | 13.68B | 16.89B | 6.8864 |
![]()
MRK
Merck Co Inc
|
84.59 | 214.78B | 63.43B | 16.42B | 14.72B | 6.4861 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-10-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2025-09-23 | Hochstufung | Guggenheim | Neutral → Buy |
2025-07-23 | Hochstufung | Erste Group | Hold → Buy |
2025-05-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2024-12-10 | Fortgesetzt | BofA Securities | Neutral |
2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
2024-07-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
2024-05-30 | Fortgesetzt | Goldman | Neutral |
2024-04-18 | Hochstufung | HSBC Securities | Hold → Buy |
2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2023-12-01 | Hochstufung | UBS | Neutral → Buy |
2023-10-05 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-09-06 | Eingeleitet | HSBC Securities | Hold |
2023-05-30 | Fortgesetzt | Citigroup | Buy |
2023-03-29 | Eingeleitet | UBS | Neutral |
2023-03-01 | Eingeleitet | Guggenheim | Neutral |
2022-11-18 | Eingeleitet | Credit Suisse | Neutral |
2022-10-18 | Eingeleitet | Barclays | Equal Weight |
2022-10-14 | Bestätigt | BofA Securities | Neutral |
2022-06-22 | Eingeleitet | Daiwa Securities | Outperform |
2022-05-23 | Fortgesetzt | SVB Leerink | Outperform |
2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2022-03-16 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
2021-12-17 | Eingeleitet | Goldman | Neutral |
2021-12-15 | Bestätigt | Citigroup | Buy |
2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-05-28 | Fortgesetzt | Morgan Stanley | Overweight |
2020-04-28 | Herabstufung | UBS | Buy → Neutral |
2020-04-22 | Hochstufung | BofA/Merrill | Neutral → Buy |
2020-03-05 | Eingeleitet | Citigroup | Buy |
2019-12-19 | Hochstufung | Barclays | Equal Weight → Overweight |
2019-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2019-11-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
2019-10-16 | Hochstufung | Atlantic Equities | Underweight → Neutral |
2019-10-11 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2019-07-12 | Fortgesetzt | Credit Suisse | Outperform |
2019-05-28 | Eingeleitet | Goldman | Buy |
2019-01-23 | Bestätigt | Barclays | Equal Weight |
2018-07-12 | Hochstufung | Goldman | Sell → Neutral |
2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
2018-04-23 | Bestätigt | Citigroup | Neutral |
2018-04-18 | Bestätigt | Stifel | Hold |
2018-01-24 | Bestätigt | Stifel | Hold |
2018-01-12 | Bestätigt | Wells Fargo | Outperform |
2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
2017-10-18 | Bestätigt | RBC Capital Mkts | Outperform |
2017-10-18 | Bestätigt | Stifel | Hold |
Alle ansehen
Johnson Johnson Aktie (JNJ) Neueste Nachrichten
Bucs rookie WR Tez Johnson confused why he received MVP chants before learning they were for Baker Mayfield - CBS Sports
Ben Johnson Delivers Strong Postgame Speech to Bears After Win - Newsweek
Johnson & Johnson Stock Moves Higher After Delivering Robust Q3 Growth - TradingView
'The View': Whoopi Goldberg Delivers Blunt Message to Trump & Mike Johnson About Government Shutdown - TV Insider
Johnson & Johnson stock falls after company lays out plan to spin off orthopaedics business - The Economic Times
Dwayne Johnson flexes his acting abilities in ‘The Smashing Machine’ - The Hofstra Chronicle
Government shutdown could be the longest ever, House Speaker Johnson warns - WBBJ TV
J&J lays out plan to splinter orthopedics business into separate companyABC News - ABC News - Breaking News, Latest News and Videos
Mike Johnson to rally international support for Trump Nobel Peace Prize nomination - The Hill
Johnson & Johnson CEO Confirms No Finalized Drug Pricing Agreement with White House - geneonline.com
House Speaker Mike Johnson addresses reporters as federal shutdown continues - WCNC
Johnson on Government shutdown day 14 - LiveNOW from FOX
J&J to spin off orthopedics business, sees 2026 sales growth of over 5% - Reuters
Boris Johnson gave parents 'false hope' over schools reopening, Gavin Williamson tells Covid inquirylive updates - BBC
Dwayne Johnson Jokes He's 'Putting That Voodoo' on Travis Kelce to Have Kids with Taylor Swift - People.com
Johnson & Johnson (NYSE:JNJ) Sets New 12-Month High Following Strong Earnings - MarketBeat
Colts sign T Bayron Matos to practice squad, release T Marcellus Johnson from practice squad - Colts.com
J&J Raises Sales Guidance, Will Split Off Orthopedics Unit - Bloomberg.com
Johnson & Johnson Orthopedics Split - WV News
Everything Ben Johnson Had To Say After Thrilling Comeback Win Over Commanders - Heavy Sports
UK’S Johnson thinks he’s world’s best shooter - Bowling Green Daily News
J&J plans to spin out orthopedics business - MedTech Dive
Johnson Y-Axis Adjustment® (“Ring Dinger®”) Clarified as In-Scope Care Under Texas Law; Advanced Chiropractic Equipment LLC Addresses Confusion with Y-Strap Traction - StreetInsider
WATCH NOW: Mayor Van Johnson hosts weekly address - WSAV-TV
Speaker Johnson Warns Government Shutdown Could Be the Longest in U.S. History - Democracy Now!
JNJ Earnings: Johnson & Johnson Stock Falls Despite Guidance Boost and Orthopedics Spin-Off Plans - TipRanks
J&J reportedly in talks to buy Protagonist - statnews.com
Johnson & Johnson Stock Brushes Off Beat-and-Raise - Schaeffer's Investment Research
Lorraine L. Johnson, age 72 - Moody County Enterprise
House Speaker Mike Johnson Speaks As Government Shutdown Continues - WUSA9
Speaker Johnson Holds News Conference on Day 14 of Government Shutdown - C-SPAN
Johnson & Johnson delivers impressive 3rd quarter gains - Rolling Out
Tad Boyle excited about Hargress, Johnson point guard rotation - The Ralphie Report
Majority Speaker Mike Johnson Says Government Shutdown Could Be Longest Ever - NewsOne
Johnson & Johnson to Announce Q3 Earnings Amid Pfizer’s Tariff and Drug Pricing Agreements - geneonline.com
Johnson & Johnson reports results for the quarter ended September 30Earnings Summary - TradingView
Johnson & Johnson outlook, Oracle & AMD team up, GM's EV charge - Yahoo Finance
Compared to Estimates, Johnson & Johnson (JNJ) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Johnson & Johnson to Separate DePuy Synthes Orthopaedics Biz - Medical Product Outsourcing
Johnson & Johnson (JNJ) Stock: Q3 Earnings Beat Expectations as Orthopaedics Spin-Off Announced - CoinCentral
Johnson & Johnson to spin off orthopaedics division - Financial Times
Jason McCourty: Ben Johnson, Caleb Williams 'just getting started' - espn.com
Mario Cristobal References Jimmy Johnson to Emphasize Special Teams Against Louisville - Sports Illustrated
Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again (NYSE:JNJ) - Seeking Alpha
S&P Drug Titan J&J Dips After Announcing A Surprise Spinoff - Investor's Business Daily
Johnson & Johnson To Separate Orthopedics Business, Boosts Annual Sales Outlook - Benzinga
Johnson & Johnson Raises Earnings Guidance for 2025 - MarketScreener
Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping. - Barron's
TD Bank and Venture Valley Bring Financial Education and Entrepreneurship to Johnson C. Smith University Through Gaming Competition - PR Newswire
Johnson & Johnson (NYSE:JNJ) Announces Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Johnson & Johnson beats Street in Q3, raises 2025 revenue outlook - MassDevice
Finanzdaten der Johnson Johnson-Aktie (JNJ)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):